The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Article The introduction of blood type screening followed by anti-D prophylaxis is a success story in perinatology. New treatment principles are now being developed for alloimmunisation in pregnancy.

University Hospitals is now offering endoscopic spine surgery for patients needing treatment for back pain due to herniated ...

With the evolving technologies and methodologies of pain management treatment, experts are encouraging folks suffering from chronic pain to get with a pain ...

Medically reviewed by Smita Patel, DO It can be tricky to pinpoint the cause of pain at the base of your skull, the area ...

Here's a wrap-up of news on medicines and clinical treatments, including a win for the AMA, and updates from the TGA, PBS, and MBS, as well as information on new guidelines, publications and ...

The New York Mets have emerged as a World Series ... Alonso is now receiving the hardball treatment from Steve Cohen, who we know damn well he has no shortage of cash in his bank account.” ...

Nail services are available in a new pamper room that has recently opened alongside the spa lounge, complete with six foot treatment stations and two manicure stations. The Lost Spring boasts ...

The Belgian biotechnologist Els Torreele helped found the Drugs for Neglected Diseases Initiative (DNDi), a nonprofit that seeks new treatments for conditions that affect more than 1 billion people.

But a new mouse study shows one possible use case for xenon — as a treatment for Alzheimer’s disease. The paper, published Wednesday in Science Translational Medicine, shows the potential of ...